Skip to main content
SpringerLink
Log in

Breast cancer and the NSABP-B32 sentinel node trial

  • Review Article
  • Published:
Breast Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cabanes PA, Salmon RJ, Vilcoq JR,et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie.Lancet 339:1245–1248, 1992.

    Article  PubMed  CAS  Google Scholar 

  2. Fisher B, Redmond C, Fisher ER,et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.N Engl J Med 312:674–681, 1985.

    PubMed  CAS  Google Scholar 

  3. Hayward JI: The Guy’s Hospital trials on breast conservation. In: Harris JR, Hellman S, Silen W, eds. Conservative Management of Breast Cancer: New Surgical and Radiotherapeutic Techniques. Philadelphia, J.B. Lippincott, pp77–90, 1983.

    Google Scholar 

  4. Atkins H, Hayward JL, Klugman DJ, Wayte AB: Treatment of early breast cancer: a report after ten years of a clinical trial.Br Med J 2:423–429, 1972.

    Article  PubMed  CAS  Google Scholar 

  5. Langlands AO, Prescott RJ, Hamilton T: A clinical trial in the management of operable cancer of the breast.Br J Surg 67:170–174, 1980.

    Article  PubMed  CAS  Google Scholar 

  6. Johansen H, Kaae S, Schiodt T: Simple mastectomy with postoperative irradiation versus extended radical mastectomy in breast cancer. A twenty-five-year follow-up of a randomized trial.Ada Oncol 29:709–715, 1990.

    Article  CAS  Google Scholar 

  7. Orr RK: The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis.Ann Surg Oncol 6:109–116, 1999.

    Article  PubMed  CAS  Google Scholar 

  8. Krag DN, Single RM: Breast cancer survival according to number of nodes removed.Ann Surg Oncol 10:1152–1159, 2003.

    Article  PubMed  Google Scholar 

  9. Bland KI, Scott-Conner CE, Menck H, Winchester DP: Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival.J Am Coll Surg 188:586–595; discussion 95-96, 1999.

    Article  PubMed  CAS  Google Scholar 

  10. van der Wal B, Butzelaar R, van der Meij S, Boermeester M: Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.EurJ Surg Oncol 28:481, 2002.

    Article  Google Scholar 

  11. Sosa JA, Diener-West M, Gusev Y,et al: Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.Ann Surg Oncol 5:140–149, 1998.

    Article  PubMed  CAS  Google Scholar 

  12. Mathiesen O, Carl J, Bonderup O, Panduro J: Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients.Acta Oncol 29:721–725, 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Axelsson CK, Mouridsen HT, Zedeler K: Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG).Eur J Cancer 28A(8– 9):1415–1418, 1992.

    Article  PubMed  CAS  Google Scholar 

  14. Le Voyer TE, Sigurdson ER, Hanlon AL,et al: Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of inter-group trial INT-0089.J Clin Oncol 21:2912–2919, 2003.

    Article  PubMed  Google Scholar 

  15. Tepper JE, O’Connell MJ, Niedzwiecki D,et al: Impact of number of nodes retrieved on outcome in patients with rectal cancer.J Clin Oncol 19:157–163, 2001.

    PubMed  CAS  Google Scholar 

  16. Chan AD, Essner R, Wanek LA, Morton DL: Judging the therapeutic value of lymph node dissections for melanoma.J Am Coll Surg 191:16–22; discussion-3, 2000.

    Article  PubMed  CAS  Google Scholar 

  17. Saphir O, Amromin G: Obscure axillary lymph-node metastasis in carcinoma of the breast.Cancer 1:238–241, 1948.

    Article  PubMed  CAS  Google Scholar 

  18. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O’Connell M: Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study.Cancer 88:1099–1107, 2000.

    Article  PubMed  CAS  Google Scholar 

  19. Schoenfeld A, Luqmani Y, Sinnett HD, Shousha S, Coombes RC: Keratin 19 mRNA measurement to detect micrometastases in lymph nodes in breast cancer patients.Br J Cancer 74:1639–1642, 1996.

    PubMed  CAS  Google Scholar 

  20. Lockett MA, Baron PL, O’Brien PH,et at: Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel.J Am Coll Surg 187:9–16, 1998.

    Article  PubMed  CAS  Google Scholar 

  21. Heller R, Becker J, Wasselle J,et al: Detection of submicroscopic lymph node metastases in patients with melanoma.Arch Surg 126:1455–1459; discussion 9-60, 1991.

    PubMed  CAS  Google Scholar 

  22. Hall JC, Platell C, Hall JL: Surgery on trial: an account of clinical trials evaluating operations.Surgery 124:22–27, 1998.

    PubMed  CAS  Google Scholar 

  23. Bonenkamp JJ, Hermans J, Sasako M, van De Velde CJ: Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer.Gastric Cancer 1:152–159, 1998.

    Article  PubMed  Google Scholar 

  24. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA: Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma.Ann Surg Oncol 7:361–366, 2000.

    Article  PubMed  CAS  Google Scholar 

  25. Albo D, Wayne JD, Hunt KK,et al: Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer.Am J Surg 182:393–398, 2001.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, University of Vermont College of Medicine Given Bldg Rm E309 Burlington, 05405, VT, USA

    David Krag

  2. Department of Surgery, University of Vermont College of Medicine, USA

    Seth Harlow

  3. Department of Human Onocology, Drexel School of Medicine Allegheny General Hospital, USA

    Thomas Julian

Authors
  1. David Krag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seth Harlow
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas Julian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Krag.

About this article

Cite this article

Krag, D., Harlow, S. & Julian, T. Breast cancer and the NSABP-B32 sentinel node trial. Breast Cancer 11, 221–224 (2004). https://doi.org/10.1007/BF02984541

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02984541

Key words

Search

Navigation